Curis, Inc. (CRIS) Income Statement

NASDAQ: CRISRevenue, profits, margins and EPS over 10 years.

CRIS 2025 at a glance

Fiscal year ended December 31, 2025 · U.S. dollars
Revenue−13.4%
$9.4M
2025 · hover or tap a bar for each year
2016: $7.5M (−4.5%)2017: $9.9M (+31.5%)2018: $10.4M (+5.4%)2019: $10.0M (−4.1%)2020: $10.8M (+8.3%)2021: $10.6M (−1.7%)2022: $10.2M (−4.6%)2023: $10.0M (−1.4%)2024: $10.9M (+8.8%)2025: $9.4M (−13.4%)
20162025
Gross profit−13.1%
$9.4M
2025 · hover or tap a bar for each year
2016: $7.1M (−4.6%)2017: $9.4M (+31.9%)2018: $9.9M (+4.9%)2019: $9.5M (−3.7%)2020: $10.3M (+8.4%)2021: $10.1M (−1.8%)2022: $9.9M (−2.1%)2023: $10.0M (+1.2%)2024: $10.8M (+7.9%)2025: $9.4M (−13.1%)
20162025
Operating income
−$32.9M
2025 · hover or tap a bar for each year
2016: −$58.0M2017: −$49.8M2018: −$29.3M2019: −$24.4M2020: −$24.9M2021: −$42.1M2022: −$53.0M2023: −$48.3M2024: −$44.5M2025: −$32.9M
20162025
Net income
−$7.6M
2025 · hover or tap a bar for each year
2016: −$60.4M2017: −$53.3M2018: −$32.6M2019: −$32.1M2020: −$29.9M2021: −$45.4M2022: −$60.3M2023: −$47.4M2024: −$43.4M2025: −$7.6M
20162025
EPS (diluted)
−$58.35
2025 · hover or tap a bar for each year
2016: −$340.752017: −$640.252018: −$404.002019: −$19.402020: −$112.392021: −$140.152022: −$196.122023: −$179.202024: −$116.852025: −$58.35
20162025
Net profit margin+317.5 pts
−80.3%
2025 · hover or tap a point for each year
2016: −802.6% (−53.9 pts)2017: −538.7% (+263.9 pts)2018: −312.4% (+226.3 pts)2019: −321.3% (−8.9 pts)2020: −276.0% (+45.3 pts)2021: −426.7% (−150.6 pts)2022: −593.6% (−167.0 pts)2023: −473.0% (+120.6 pts)2024: −397.8% (+75.3 pts)2025: −80.3% (+317.5 pts)
20162025

CRIS revenue and net income

RevenueNet incomeNet margin (right axis)

Where CRIS's revenue goes

2025
Revenue
$9.4M100.0%
Cost of revenue
−$45,000−0.5%
Gross profit
$9.4M99.5%
Research & development
−$28.3M−299.2%
Sales, general & admin
−$14.0M−148.7%
Operating income
−$32.9M−348.4%
Interest & other income
$25.3M268.1%
Net income
−$7.6M−80.3%

Each bar shows an amount and its share of revenue. CRIS kept −80.3% of revenue as net income.

CRIS profit margins

GrossOperatingNet

CRIS growth rates

to 2025
1 year3 years5 years10 years
Revenue−13.4%−2.4%−2.7%+1.8%
Gross profit−13.1%−1.7%−1.8%+2.3%
Operating income————
Net income————
EPS (diluted)————

1-year change and average annual growth (CAGR) over 3, 5 and 10 fiscal years. "—" when a starting value was zero or negative.

CRIS quarterly EPS vs estimates

Reported EPSAnalyst estimate

Curis beat the analyst EPS estimate in 5 of the last 8 quarters. Next report: November 5, 2026 (estimate $-2.29).

CRIS income statement

Curis, Inc. annual income statement
2025202420232022202120202019201820172016
Revenue$9.4M$10.9M$10.0M$10.2M$10.6M$10.8M$10.0M$10.4M$9.9M$7.5M
Cost of revenue$45,000$98,000$229,000$257,000$533,000$534,000$503,000$563,000$496,000$399,000
Gross profit$9.4M$10.8M$10.0M$9.9M$10.1M$10.3M$9.5M$9.9M$9.4M$7.1M
Research & development$28.3M$38.6M$39.5M$43.3M$34.9M$23.1M$22.3M$24.4M$33.3M$31.6M
Sales, general & admin$14.0M$16.8M$18.6M$19.6M$17.3M$12.1M$11.6M$14.8M$25.8M$15.6M
Total operating expenses$42.3M$55.4M$58.4M$62.9M$52.2M$35.2M$33.9M$39.2M$59.2M$47.2M
Operating income−$32.9M−$44.5M−$48.3M−$53.0M−$42.1M−$24.9M−$24.4M−$29.3M−$49.8M−$58.0M
Interest income$316,000$1.8M$2.8M$1.1M$211,000$63,000$614,000$684,000$513,000$406,000
Interest expense$2.2M$615,000$2.0M$4.8M$4.5M$5.1M$4.8M$3.9M$4.0M$2.8M
Income before taxes−$7.6M−$43.4M−$47.4M−$56.7M−$45.4M−$29.9M−$32.1M−$32.6M−$53.3M−$60.4M
Income taxes——−$255,000$3.7M$5.2M$5.0M$4.7M$683,000$3.9M$2.6M
Net income−$7.6M−$43.4M−$47.4M−$60.3M−$45.4M−$29.9M−$32.1M−$32.6M−$53.3M−$60.4M
EBITDA−$5.2M−$42.6M−$48.3M−$52.8M−$40.8M−$24.7M−$27.2M−$28.5M−$49.1M−$57.4M
EPS (diluted)−$58.35−$116.85−$179.20−$196.12−$140.15−$112.39−$19.40−$404.00−$640.25−$340.75
Gross margin99.5%99.1%100.0%97.5%95.0%95.1%95.0%94.6%95.0%94.7%
Operating margin−348.4%−408.3%−482.2%−521.7%−395.0%−229.8%−243.5%−281.3%−502.7%−771.1%
Net margin−80.3%−397.8%−473.0%−593.6%−426.7%−276.0%−321.3%−312.4%−538.7%−802.6%

Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported in CRIS's financial statements (latest annual report filed March 24, 2026); data from EODHD. Sales, general & administrative expenses include sales and marketing.

CRIS financial results

In fiscal year 2025 (ended December 31, 2025), Curis reported revenue of $9.4 million, down 13.4% from the year before. It had a net loss of $7.6 million, a net profit margin of −80.3%. Diluted earnings per share came to −$58.35. Over five years revenue grew at an average rate of −2.7% a year.

See the CRIS stock overview for the latest quote and news, or the CRIS chart for price history and technical indicators.

CRIS income statement FAQ

What is Curis's annual revenue?

Curis reported total revenue of $9.4 million for fiscal year 2025, which ended on December 31, 2025. That was down 13.4% from $10.9 million the previous year.

Is Curis profitable?

No. Curis reported a net loss of $7.6 million in fiscal 2025, a net profit margin of −80.3%; its operating margin was −348.4%.

What is Curis's gross margin?

Curis's gross margin was 99.5% in fiscal 2025: for every $100 of revenue, Curis kept $100 after the direct cost of its products and services.

How much does Curis spend on research and development?

Curis spent $28.3 million on research and development in fiscal 2025, 299.2% of revenue.

How fast is Curis growing?

Revenue grew −2.7% a year on average over the last five fiscal years, from $10.8 million to $9.4 million.

What are Curis's earnings per share?

Curis earned $-58.35 per diluted share in fiscal 2025, compared with $-116.85 a year earlier.

When will Curis report its next earnings?

Curis is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes.

When does Curis's fiscal year end?

Curis's fiscal year ends in December. The latest annual report covers the year ended December 31, 2025 and was filed on March 24, 2026.

Biotechnology income statements